透過您的圖書館登入
IP:3.145.86.183
  • 學位論文

PI3K抑制劑wortmannin增強iNOS表現之分子機制探討

Molecular Mechanisms of PI3K inhibitor wortmannin on the augmentation of iNOS expression in macrophages

指導教授 : 梁有志

摘要


構成細胞膜的主要成份是磷脂質,其中磷脂醯肌醇4,5二磷酸(Phosphatidylinositol (4,5)-bisphosphate , PtdIns(4,5)P2)可作為磷脂醯肌醇激酶(phosphatidylinositol 3-kinase,PI3K)和磷脂醯肌醇特異性磷酸脂肪酶(phosphoinositide specific phospholipase C,PI-PLC)的受質,當PtdIns(4,5)P2作為PI3K的受質時,PI3K會將PtdIns(4,5)P2磷酸化生成磷脂醯肌醇3,4,5三磷酸(Phosphatidylinositol (3,4,5)-triphosphate,PtdIns (3,4,5)P3)。當PtdIns(4,5)P2 作為PI-PLC的受質時,PI-PLC會將PtdIns(4,5)P2水解為肌醇-1,4,5-三磷酸(inositol 1,4,5-trisphosphate,Ins(1,4,5)P3)和二醯甘油(diacylglycerol,DG,DAG)。我們的研究主要是探討PI3K抑制劑wortmannin增強誘導型一氧化氮合成酶(induceble nitric oxide synthase, iNOS)表現的分子機制。首先,經由wortmannin處理的巨噬細胞,其Ins(1,4,5)P3產物和iNOS的表現均會增加。而轉殖p85 siRNA(small interfering RNA)的巨噬細胞,因為PI3K的活性消失,也會增強iNOS的表現;相反的,用表現質體ras-p110轉殖的巨噬細胞,因為PI3K的過度活化,使得原本增強的iNOS卻顯著的下降了。此外,在脂質多醣體(lipopolysaccharide, LPS)活化的巨噬細胞裡,過度表現wild-type Akt及dominant-negative Akt,對於增強iNOS的表現並沒有影響。如果使用PI-PLC的抑制劑U73122處理在LPS活化的巨噬細胞,除了iNOS的表現會下降之外,並且也會降低ERK(extracellar signal-regulated kinase,)、JNK(c-Jun N-terminal kinase)、p38 (protein 38)的磷酸化及AP-1(activating protein -1,)的轉錄活性。但是不論「有」和「無」wortmannin處理下,在LPS活化的巨噬細胞,其kappa B 激酶抑制子(inhibitor kappa B, IkappaB)的降解、核因子kappa B(nuclear factor kappa B, NF-kappa B)的結合活性(EMSA)、NF-kappa B的轉錄活性(luciferase reporter assay)均沒有變化;但有wortmannin處理的巨噬細胞其AP-1的結合活性(EMSA)及AP-1的轉錄活性(luciferase reporter assay)均明顯增加。因此我們提出:使用PI3K的抑制劑wortmannin處理的巨噬細胞,其所增強iNOS的表現是透過PI-PLC下游的訊號及轉錄因子AP-1轉錄活性的增強,因而促進iNOS的表現增加。換言之;PI3K的抑制劑wortmannin處理的巨噬細胞,所增強的iNOS表現,並不依賴Akt路徑、及NF-kappa B轉錄因子。

並列摘要


Phosphatidylinositol (4,5)-bisphosphate (PtdIns(4,5)P2) has been known to serve as substrate for phosphatidylinositol 3-kinase (PI3K) and phosphoinositide-specific phospholipase C (PI-PLC), and that can produce PtdIns(3,4,5)P3 and inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) & diacylglycerol (DAG), respectively. To elucidate the role of PI-PLC during activated-macrophages treated with PI3K inhibitor wortmannin, we examined the effects of wortmannin on the enhancement of PI-PLC downstream signals and that leading to increase of inducible nitric oxide synthase (iNOS) expression in lipopolysaccharide (LPS)-activated macrophages. Here, we report that wortmannin inhibited PI3K activity but enhanced PI-PLC downstream signals, and subsequently increased iNOS expression independently of Akt & NF-kB pathways. First, wortmannin treatment enhanced Ins(1,4,5)P3 production and iNOS expression in LPS-activated macrophages. Inhibition of PI3K by p85 siRNA also showed an enhancement of iNOS expression. On the other hand, overexpression of PI3K by ras-p110 expression plasmid significantly decreased iNOS expression in LPS-activated macrophages. In addition, overexpression of wild-type or dominant-negative Akt expression plasmid did not affect the iNOS expression in LPS-activated macrophages. Second, treatment of PI-PLC inhibitor U73122 reversed the enhancement of iNOS expression, the increase of phosphorylation level of ERK, JNK & p38, and the increase of AP-1-dependent gene expression in wortmannin-treated & LPS-activated macrophages. However, I kappa B degradation, NF-kappaB binding activity by EMSA assay, and NF-kappa B-dependent gene expression by luciferase reporter assay did not change during LPS-activated macrophages with or without wortmannin. We propose that the inhibition of PI3K by wortmannin in mouse macrophages enhances the PI-PLC downstream signals, and subsequently increases the LPS induction of iNOS expression independently of Akt pathway, and AP-1 but not NF-kappa B mediates the enhancement of iNOS expression.

並列關鍵字

PI3K PtdIns(4,5)P2 Ins(1,4,5)P3 iNOS LPS

參考文獻


1. Adams, D. O., and T. A. Hamilton. 1984. The cell biology of macrophage activation. Annu. Rev. Immunol. 2: 283-318.
2. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
3. Mayer, B., and B. Hemmens. 1997. Biosynthesis and action of nitric oxide in mammalian cells. Trends Biochem. Sci. 22: 477-481.
4. Kleinert, H., A. Pautz, K. Linker, and P. M. Schwarz. 2004. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500: 255-266.
5. Fujihara, M., M. Muroi, K. Tanamoto, T. Suzuki, H. Azuma, and H. Ikeda. 2003. Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex. Pharmacol. Ther. 100: 171-194.

延伸閱讀